These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Intra-dialytic hypotension: Identifying patients most at risk. Author: Sangala N, Gangaram V, Atkins K, Elliot G, Lewis R. Journal: J Ren Care; 2017 Jun; 43(2):92-97. PubMed ID: 28470959. Abstract: BACKGROUND: Intra-dialytic hypotension (IDH) remains a frequent but serious complication of haemodialysis. METHODS: We performed a retrospective observational analysis of our prevalent dialysis population extracting data from an online database. RESULTS: Four hundred and thirty-two patients underwent 21 consecutive outpatient dialysis sessions during the study period: Of the 9,072 dialysis sessions studied, 438 were complicated by episodes of IDH (4.8%). 266/432 patients were asymptomatic whilst 166/432 experienced at least one episode of IDH. Symptomatic patients had significantly lower pre-dialysis systolic blood pressures (137 mmHg compared with 146 mmHg p < 0.0001) and demonstrated a greater per cent drop in their systolic blood pressure (delta systolic) before and after dialysis (9.7% vs. 4.1% p < 0.0001). Patients taking either a single or no anti-hypertensive agents had a significantly higher delta systolic than those on two or more anti-hypertensive agents (7.6% vs. 2.2% p < 0.01) and were almost 50% more likely to suffer from IDH (RR = 1.48, p = 0.017). Using logistical regression we identified pre-dialysis systolic blood pressure and delta systolic blood pressure as strong predictor variables for IDH (p < 0.0001). We constructed a model able to calculate the risk of an individual patient suffering with IDH using delta systolic and pre-dialysis systolic blood pressure. A ROC analysis suggests this to be an accurate model (AUC = 0.79). CONCLUSION: Delta systolic blood pressure is clinically useful in identifying patients most at risk of IDH. Anti-hypertensive medication use is associated with a lower delta systolic and a lower risk of IDH.[Abstract] [Full Text] [Related] [New Search]